Covid and Oxytocin: Looking for Microbial Symbiosis
PDF

Keywords

Oxytocin
Covid-19
Microbiota
Symbiosis

Abstract

Oxytocin is a hormone with broad implications for general health. This hormone has anti-inflammatory and antioxidant protective effects and has received particular attention due to the pandemic of COVID-19. This review examines materials on the role of microbial symbiosis in COVID-19 and the effect of microbiota on oxytocin. It opens new potential prospects for the use of microbiota and new “nature-like” technologies.

https://doi.org/10.48037/mbmj.v8i10.1312
PDF

References

Lee HJ, Macbeth AH, Pagani JH, Young WS. Oxytocin: the great facilitator of life. Prog Neurobiol 2009;88(2):127-151. Available from: https://doi.org/10.1016/j.pneurobio.2009.04.001

Diep PT, Chaudry M, Dixon A, Chaudry F, Kasabri V. Is Oxytocin the panacea for Long-Covid? 2021. Available from: https://doi.org/10.13140/RG.2.2.18830.28484

Carter CS, Kenkel WM, MacLean EL, et al. Is Oxytocin “Nature’s Medicine?” Pharmacol Rev 2020;72(4):829-861. Available from: https://doi.org/10.1124/pr.120.019398

Quintana DS, Guastella AJ. An allostatic theory of oxytocin. Trends Cogn Sci 2020;24(7):515-528. Available from: https://doi.org/10.1016/j.tics.2020.03.008

Ding C, Leow MK, Magkos F. Oxytocin in metabolic homeostasis: implications for obesity and diabetes management. Obes Rev 2019;20(1):22-40. Available from: https://doi.org/10.1111/obr.12757

Diep PT, Talash K, Kasabri V. Hypothesis: Oxytocin is a direct COVID-19 antiviral. Med Hypotheses 2020;145:110329. Available from: https://doi.org/10.1016/j.mehy.2020.110329

Diep PT. Is there an underlying link between COVID-19, ACE2, oxytocin and vitamin D? Med Hypotheses 2021;146:110360. Available from: https://doi.org/10.1016/j.mehy.2020.110360

Kasabri V, Shawakri E, Akour A, et al. Cross-sectional correlates of increased IL-18 but reduced fetuin-A and oxytocin with adiposity and blood indices in metabolic syndrome patients with and without prediabetes. Ther Adv Endocrinol Metab 2018;9(12):329-338. Available from: https://doi.org/10.1177/2042018818788802

Buemann B, Marazziti D, Uvnäs-Moberg K. Can intravenous oxytocin infusion counteract hyperinflammation in COVID-19 infected patients? World J Biol Psychiatry 2020 Sep:1-12.Available from: https://doi.org/10.1080/15622975.2020.1814408

Hekimoglu AT, Toprak G, Akkoc H. Oxytocin ameliorates remote liver injury induced by renal ischemia-reperfusion in rats. Korean J Physiol Pharmacol 2013;17(2):169–173. Available from: https://doi.org/10.4196/kjpp.2013.17.2.169

Jankowski M, Broderick TL, Gutkowska J. The role of oxytocin in cardiovascular protection. Front Psychol 2020;11:2139. Available from: https://doi.org/10.3389/fpsyg.2020.02139.

Noiseux N, Borie M, Desnoyers A, et al. Preconditioning of stem cells by oxytocin to improve their therapeutic potential. Endocrinology 2012;153(11):5361-72. Available from: https://doi.org/10.1210/en.2012-1402.

Gutkowska J, Jankowski M. Oxytocin: old hormone, new drug. Pharmaceuticals (Basel) 2009;2(3):168-183. Available from: https://doi.org/10.3390/ph203168

Bukharin OV, Stadnikov AA, Perunova NB. The role of oxytocin and microbiota in regulation of pro- and eukaryote interactions in infection. Ekaterinburg: UB RAS., 2018; 247. (In Russ.)

Xu PF, Fang MJ, Jin YZ, Wang LS, Lin DS. Effect of oxytocin on the survival of random skin flaps. Oncotarget 2017; 8(54):92955-92965. Available from: https://doi.org/10.18632/oncotarget.21696

Bukharin OV. Natural mechanisms that underlie the defense of host organisms against infections. Herald of the Russian Academy of Sciences 2019;89(4):426–431. Available from: https://doi.org/10.1134/S1019331619040014

Bukharin OV, Perunova NB. The role of microbiota in the regulation of homeostasis in the human body during infection. Journal of Microbiology, Epidemiology and Immunobiology 2020; 97(5):458-466. Available from: https://doi.org/10.36233/0372-9311-2020-97-5-8

Ahlawat S, Asha, Sharma KK. Immunological co-ordination between gut and lungs in SARS-CoV-2 infection. Virus Res 2020;286:198103. Available from: https://doi.org/10.1016/j.virusres.2020.198103

Dhar D, Mohanty A. Gut microbiota and Covid-19- possible link and implications. Virus Res 2020;285:198018. Available from: https://doi.org/10.1016/j.virusres.2020.198018

Viana SD, Nunes S, Reis F. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - role of gut microbiota dysbiosis. Ageing Res Rev 2020;62:101123. Available from: https://doi.org/10.1016/j.arr.2020.101123

Zuo T, Zhan H, Zhang F, et al. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology 2020;159(4):1302-1310.e5. Available from: https://doi.org/10.1053/j.gastro.2020.06.048

Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology 2020;159(1):81-95. Available from: https://doi.org/10.1053/j.gastro.2020.03.065

Ghoshal UC, Ghoshal U, Dhiman RK. Gastrointestinal and hepatic involvement in severe acute respiratory syndrome Coronavirus 2 infection: a review. J Clin Exp Hepatol 2020;10(6):622–628. Available from: https://doi.org/10.1016/j.jceh.2020.06.002

Sarkesh A, Daei Sorkhabi A, Sheykhsaran E, et al. Extrapulmonary clinical manifestations in COVID-19 patients. Am J Trop Med Hyg 2021;103(5):1783-1796. Available from: https://doi.org/10.4269/ajtmh.20-0986

Gasmi A, Tippairote T, Mujawdiya PK, et al. The microbiota-mediated dietary and nutritional interventions for COVID-19. Clin Immunol 2021;226:108725. Available from: https://doi.org/10.1016/j.clim.2021.108725

Iacucci M, Cannatelli R, Labarile N, et al. Endoscopy in inflammatory bowel diseases during the COVID-19 pandemic and post-pandemic period. Lancet Gastroenterol Hepatol 2020;5(6):598-606. Available from: https://doi.org/10.1016/S2468-1253(20)30119-9

Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut 2020;69:997–1001. Available from: https://doi.org/10.1136/gutjnl-2020-321013

Song Y, Liu P, Shi XL, et al. SARS-CoV-2 induced diarrhoea as onset symptom in patient with COVID-19. Gut 2020;69:1143–1144. Available from: https://doi.org/10.1136/gutjnl-2020-320891

Ng SC, Tilg H. COVID-19 and the gastrointestinal tract: more than meets the eye. Gut 2020; 69(6):973-974. Available from: https://doi.org/10.1136/gutjnl-2020-321195

Groves HT, Cuthbertson L, James P, et al. Respiratory disease following viral lung infection alters the murine gut microbiota. Front Immunol 2018;9:182. Available from: https://doi.org/10.3389/fimmu.2018.00182

Chattopadhyay I, Shankar EM. SARS-CoV-2-Indigenous microbiota nexus: does gut microbiota contribute to inflammation and disease severity in COVID-19? Front Cell Infect Microbiol 2021;11:590874. Available from: https://doi.org/10.3389/fcimb.2021.590874

Zhao Y, Liu Y, Li S, et al. Role of lung and gut microbiota on lung cancer pathogenesis. J Cancer Res Clin Oncol 2021 May 20. Available from: https://doi.org/10.1007/s00432-021-03644-0

Aktas B, Aslim B. Gut-lung axis and dysbiosis in COVID-19. Turk J Biol 2020;44(3):265-272. Available from: https://doi.org/10.3906/biy-2005-102

Anand S, Mande SS. Diet, microbiota and gut-lung connection. Front Microbiol 2018;9:2147. Available from: https://doi.org/10.3389/fmicb.2018.02147

Scaldaferri F, Ianiro G, Privitera G, et al. The thrilling journey of SARS-CoV-2 into the intestine: from pathogenesis to future clinical implications. Inflamm Bowel Dis 2020;26(9):1306-1314. Available from: https://doi.org/10.1093/ibd/izaa181

Jiang X, Hall AB, Xavier RJ, Alm EJ. Comprehensive analysis of chromosomal mobile genetic elements in the gut microbiome reveals phylum-level niche-adaptive gene pools. PLoS One 2019;14(12):e0223680. Available from: https://doi.org/10.1371/journal.pone.0223680

Willmann M, Vehreschild MJGT, Biehl LM, et al. Distinct impact of antibiotics on the gut microbiome and resistome: a longitudinal multicenter cohort study. BMC Biol 2019;17(1):76. Available from: https://doi.org/10.1186/s12915-019-0692-y

Knight GM, Glover RE, McQuaid CF, et al. Antimicrobial resistance and COVID-19: intersections and implications. Elife 2021;10:e64139. Available from: https://doi.org/10.7554/eLife.64139

Buffington SA, Di Prisco GV, Auchtung TA, et al. Microbial reconstitution reverses maternal diet-induced social and synaptic deficits in offspring. Cell 2016;165(7):1762-1775. Available from: https://doi.org/10.1016/j.cell.2016.06.001

Poutahidis T, Kearney SM, Levkovich T, et al. Microbial symbionts accelerate wound healing via the neuropeptide hormone oxytocin. PLoS One 2013;8(10):e78898. Available from: https://doi.org/10.1371/journal.pone.0078898

Varian BJ, Poutahidis T, DiBenedictis BT, et al. Microbial lysate upregulates host oxytocin. Brain, Behavior, and Immunity 2017;61:36–49. Available from: https://doi.org/10.1016/j.bbi.2016.11.002

Varian BJ, Levkovich T, Poutahidis T, et al. Beneficial dog bacteria up-regulate oxytocin and lower risk of obesity. J Probiotics Health 2016;4:1–9. Available from: https://doi.org/10.4172/2329-8901.1000149

Negi S, Das DK, Pahari S, Nadeem S, Agrewala JN. Potential role of gut microbiota in induction and regulation of innate immune memory. Front Immunol 2019;10:2441. Available from: https://doi.org/10.3389/fimmu.2019.02441

Gareau MG, Sherman PM, Walker WA. Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 2010;7(9):503–514. Available from: https://doi.org/10.1038/nrgastro.2010.117

Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009;9(5):313-23. Available from: https://doi.org/10.1038/nri2515

Moens E, Veldhoen M. Epithelial barrier biology: good fences make good neighbours. Immunology 2012;135:1- 8. Available from: https://doi.org/10.1111/j.1365-2567.2011.03506.x

Bukharin OV, Perunova NB, Ivanova EV. Bifidoflora in human associative symbiosis. Ekaterinburg: UB RAS., 2014;212. (In Russ.)

Gill HS, Rutherfurd KJ, Cross ML Dietary probiotic supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 2001;21: 264–271. Available from: https://doi.org/10.1023/A:1010979225018

Bingula R, Filaire M, Radosevic-Robin N, et al. Desired turbulence? Gut-lung axis, immunity, and lung cancer. J Oncol 2017:5035371. Available from: https://doi.org/10.1155/2017/5035371

Fagundes CT, Amaral FA, Vieira AT, et al. Transient TLR activation restores inflammatory response and ability to control pulmonary bacterial infection in germfree mice. J Immunol 2012;188(3):1411-20. Available from: https://doi.org/10.4049/jimmunol.1101682.

McPherson AC, Pandey SP, Bender MJ, Meisel M. Systemic immunoregulatory consequences of gut commensal translocation. Trends Immunol 2021;42(2):137-150. Available from: https://doi.org/10.1016/j.it.2020.12.005

Feleszko W, Jaworska J, Rha RD, et al. Probiotic-induced suppression of allergic sensitization and airway inflammation is associated with an increase of T regulatory-dependent mechanisms in a murine model of asthma. Clin Exp Allergy 2007;37:498–505. Available from: https://doi.org/10.1111/j.1365-2222.2006.02629.x

Thibonnier M, Conarty DM, Preston JA, et al. Human vascular endothelial cells express oxytocin receptors. Endocrinology 1999;140(3):1301-9. Available from: https://doi.org/10.1210/endo.140.3.6546

Bukharin OV, Andryuschenko SV, Perunova NB, et al. Genome sequence data announcement of Bifidobacterium bifidum strain ICIS-202 isolated from a healthy human intestine stimulating active nitrogen oxide production in macrophages. Data Brief 2019;27:104761. Available from: https://doi.org/10.1016/j.dib.2019.104761

Tiso M, Schechter AN. Nitrate reduction to nitrite, nitric oxide and ammonia by gut bacteria under physiological conditions. PLoS ONE 2015;10(3):e0119712. Available from: https://doi.org/10.1371/journal.pone.0119712